Adrian Gottschalk
Chief Executive Officer · Foghorn Therapeutics Inc.
Individual
- 2026
- Apr 13, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Adrian Gottschalk's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $199.99M in TYRA purchases and sales in the last 12 months
- Catalyst4, Inc. - $191.21M in MPLT purchases and sales in the last 12 months
- John Oyler - $189.61M in ONC purchases and sales in the last 12 months
- BVF PARTNERS L P - $173.67M in KYMR purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $172.50M in KYMR purchases and sales in the last 12 months
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Adrian Gottschalk?
Adrian Gottschalk is a corporate insider, tracked as Chief Executive Officer of Foghorn Therapeutics Inc. (FHTX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Adrian Gottschalk last file a Form 4?
The most recent primary Form 4 on record is dated 13 April 2026, one of 2 filings going back to 2026.
